Cyclezyme (CYCLE) | Spotlight

Cyclezyme specializes in biotechnology. The company conducts research and development of enzymes and processes for breaking down mainly PET-based plastic products found in, for example, packaging, textiles, and composite materials. The enzymes and processes are intended for use in plastic recycling. The company was founded in 2020 and has its headquarters in Lund.

Quotes for Cyclezyme AB

Right Now

+/-: -2.25
%: −12,36%
Latest: 15.95
High: 18.8
Low: 11.6
Volume: 18 829
Turnover (SEK): 290 481
Market Value (MSEK): 34,1
Time (Latest trade): 2025-04-07 17:29

Board

CEO

Peter Falck

Chairperson of the Board

Fredrik Arrigucci

Board

Javier Linares Pastén
Lotta Amsén
Martin Bengtsson
Peter Falck

News

2025-04-02 09:20:00 Cyclezyme AB delar deltagarlänk till dagens digitala investerarpresentation
2025-03-28 13:15:00 Cyclezyme AB bjuder in till digital investerarpresentation
2025-03-25 10:00:00 Styrelseordförande Fredrik Arrigucci i Cyclezyme AB (publ) avböjer omval
2025-03-19 10:15:00 Cyclezyme AB och ledande europeisk aktör går vidare i förstudien om PET-återvinning
2025-03-18 14:15:00 Kommuniké från extra bolagsstämma i Cyclezyme AB (publ)

News agencies

2025-03-25 10:13:37 Finwire: Cyclezymes ordförande avböjer omval efter ett år på posten
2025-03-25 10:09:18 Direkt: STYRELSEORDFÖRANDE FREDRIK ARRIGUCCI AVBÖJER OMVAL
2025-03-19 10:35:54 Finwire: Cyclezyme går vidare till optimeringsfasen i förstudie om PET-återvinning
2025-02-28 09:20:53 Finwire: Stockholm Bullets - Sensys faller på vd-sorti och sänkt prognos
2025-02-28 07:44:41 Finwire: Cyclezyme avser genomföra en riktad nyemission på 3 miljoner kronor

Analysis

2024-01-12 Affärsvärlden: Cyclezyme: Lång utvecklingscykel - AFV

Largest Owners

Name	Capital %	Votes %	Date
Javier Linares-Pastén	18,41	18,41	2024-12-23
Peter Falck	18,41	18,41	2024-12-23
Jens Olsson	9,50	9,50	2023-12-22
Jens Olsson	9,50	9,50	2024-12-23
Sebastian Clausin	6,94	6,94	2024-12-23
Jimmie Landerman	5,65	5,65	2024-12-23
Per Nilsson	3,27	3,27	2024-12-23
Capital Kin AB	2,77	2,77	2024-12-23
Christian Anders Berger	2,75	2,75	2023-12-22
Avanza Pension	2,22	2,22	2024-12-23

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

Number of months that the report spans	2024	Q4 3 Months	Q3 3 Months	Q2 3 Months	Q1 3 Months	2023	2022
Total revenue MSEK	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Earnings before interest and tax MSEK	-2.14	-0.68	-0.43	-0.62	-0.41	-1.51	-1.17
Profit before tax MSEK	-2.13	-0.62	-0.45	-0.64	-0.43	-1.52	-1.17
Net profit MSEK	-2.13	-0.62	-0.45	-0.64	-0.43	-1.52	-1.17
Earnings per share SEK	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Dividend per share SEK	0.00					0.00	0.00
Equity MSEK	4.75	4.75	5.37	5.82	6.45	6.88	1.65
Fixed assets MSEK	0.23	0.23	2.95	0.25	0.26	0.26	0.00
Intangible assets MSEK	3.07	3.07	2.71	2.25	1.90	1.55	0.01
Current assets MSEK	2.50	2.50	3.35	4.31	5.20	6.34	2.03
Total asset MSEK	5.80	5.80	6.30	6.82	7.37	8.15	2.05
Long term liabilities MSEK	0.36	0.36	0.38	0.35	0.40	0.46	0.01
Current liabilities MSEK	0.70	0.70	0.55	0.65	0.52	0.81	0.38
Number of shares SEK	2.14	2.14	2.14	2.14	2.14	2.14	2.14

*Compiled data from Millistream

Upcoming reports

2025-05-15 Årsstämma 2024
2025-05-15 Delårsrapport 2025-Q1
2025-08-29 Delårsrapport 2025-Q2
2025-11-14 Delårsrapport 2025-Q3

Cyclezyme AB